Pfizer brings frequent heartburn relief OTC with new Nexium® 24HR
- Details
- Category: Pfizer

Clarification regarding Pfizer statement
- Details
- Category: AstraZeneca

AstraZeneca rejects final proposal from Pfizer
- Details
- Category: Financial
The Board of AstraZeneca PLC notes the announcement by Pfizer Inc. of its final proposal to combine the two companies. Leif Johansson, Chairman of AstraZeneca mentioned that the final proposal is a minor improvement which continues to fall short of the Board's view of value and has been rejected.
Abbott enhances its position in fast-growing Latin American market
- Details
- Category: Abbott

MedImmune and Incyte announce collaboration on immuno-oncology combination clinical trial
- Details
- Category: AstraZeneca

Boehringer Ingelheim will make detailed clinical trial data available to the scientific community
- Details
- Category: Boehringer Ingelheim

Bayer HealthCare extends access to clinical trial data
- Details
- Category: Bayer

More Pharma News ...
- Pfizer announcement and AstraZeneca statement
- More than 19,000 Novartis associates worldwide volunteer for local causes on Community Partnership Day
- Pfizer reports first-quarter 2014 results
- AstraZeneca Board rejects Pfizer proposal
- Pfizer sends letter to Rt Hon David Cameron MP regarding commitments if proposed combination with AstraZeneca is completed
- Bayer: Very successful start to 2014
- Pfizer Confirms prior discussions with AstraZeneca